Drugs / Eltrombopag PfOS
last change Jun 2026 re-read 2 minutes ago

Eltrombopag PfOS

Developed for
autoimmune thrombocytopenia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT07476846 Comparator Jun 2026 → Dec 2027 expected autoimmune thrombocytopenia Institute of Hematology & Blood Diseases Hospital, China Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Eltrombopag PfOS ClinicalTrials.gov intervention name — accepted as the source's own label NCT07476846